Bakri balloon. There were no differences between the Bakri and nonBakri groups in maternal age, BMI, parity, plurality, gestational age at delivery, insurance, or comorbidities such as prior cesarean section, hypertension, diabeties or asthma. There were no differences in duration of rupture of membranes, GBS status or intrapartum antibiotics. The Bakri group had more cesarean deliveries and a higher rate of chorioaminoitis (see table). During management of the post-partum hemorrhage, the estimated blood loss, rate of blood transfusion, number of strategies used, length of stay and ICU admissions were higher in the Bakri group (see table). The rate of post-partum endometritis was significantly higher in the Bakri group compared to the non-Bakri group (OR 19.1 CI 5.9, 62.6), as was the rate of maternal sepsis (OR 63.5 CI 5.3, 753.5). On multivariable analysis, use of a Bakri balloon in the management of post-partum hemorrhage remained independently associated with endometritis after controlling for chorioaminoitis, mode of delivery, estimated blood loss, blood transfusion, and number of strategies used. CONCLUSION: Despite the routine use of prophylactic antibiotics, we have demonstrated a significantly increased rate of endometritis with the use of Bakri balloon for postpartum hemorrhage. While this is usually well-tolerated in otherwise healthy women, caution should be exercised in women for whom an infectious complication would lead to significant morbidity and mortality. 558 Cannabidiol enhances placental permeability to xenobiotics throughout direct inhibition of breast cancer resistance protein in the human placental barrier Valeria Feinshtein, Zvi Ben-Zvi, Offer Erez, Tamar Eshkoli, Eyal Sheiner, Gershon Holcberg Ben-Gurion University of the Negev, Pharmacology, Beer-Sheva, Israel, Soroka University Medical Center, Obstetrics and Gynecology, Beer-Sheva, Israel OBJECTIVE: Illicit drugs affect pregnancy outcome, however, the mechanisms in which cannabis exert its effect is not well understood. The aims of our study are to examine the effect of acute exposure (1-2 hours) to cannabidiol (CBD) on human placental Breast Cancer Resistance Protein (BCRP) function in in-vitro and ex-vivo models. STUDY DESIGN: CBD impact on BCRP in BeWo and Jar cells was tested with Mitoxantrone (MX) (BCRP substrate) uptake assay, using Nicardipine (BCRP inhibitor) as a positive control. CBD impact on BCRP function in human placenta was examined by testing Glyburide transport (known BCRP substrate) across term, normal, human cotyledon that was dually perfused for 2 hours, with [CBD group, n 5] or without [control group, n 5] CBD. Glyburide was introduced to maternal (M) and fetal (F) compartments, and F/M ratio of its concentrations was calculated. RESULTS: CBD inhibition of BCRP-dependent MX efflux (measured by elevation of intracellular MX) is concentration dependent in both cell lines; it effect is stronger than that of Nicardipine. [BeWo cells CBD 10 M-25%; CBD 25 M-125%; and Nicardipine 53% (p 0.001); Jar cells CBD 10 M-22%; CBD 25 M-96%; and Nicardipine 65% (p 0.001)]. Similarly, in the perfused term cotyledons, F/M ratios of Glyburide concentrations at 90 and 120min. are significantly higher (by 45%) in the presence of CBD (0.85 in control group vs 1.23 in CBD group) (Figure). CONCLUSION: BCRP is inhibited by acute exposure to CBD in the human placental barrier in in-vitro and ex-vivo models. These findings suggest that marijuana consumption affects the defense mechanisms of the human placenta against xenobiotics. This effect could jeopardize fetal wellbeing, and the safety of drugs that are BCRP substrates (i.e. glyburide, folic acid) which are used in pregnant women, is questionable during cannabis consumption.
Read full abstract